Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

Por Spaeth, Erika L., Dembinski, Jennifer L., Sasser, A. Kate, Watson, Keri, Klopp, Ann, Hall, Brett, Andreeff, Michael, Marini, Frank
Publicado em 2009

Correction: Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

Por Spaeth, Erika L., Dembinski, Jennifer L., Sasser, A. Kate, Watson, Keri, Klopp, Ann, Hall, Brett, Andreeff, Michael, Marini, Frank
Publicado em 2013

The role of Dickkopf-1 in bone development, homeostasis, and disease

Por Pinzone, Joseph J., Hall, Brett M., Thudi, Nanda K., Vonau, Martin, Qiang, Ya-Wei, Rosol, Thomas J., Shaughnessy, John D.
Publicado em 2009

STAT3 can be activated through paracrine signaling in breast epithelial cells

Por Sasser A Kate, Hutzen Brian, Ball Sarah, Lieblein Jacqueline C, Lin Huey-Jen, Huang Tim HM, Hall Brett M, Lin Jiayuh
Publicado em 2008-10-01

STAT3 can be activated through paracrine signaling in breast epithelial cells

Por Lieblein, Jacqueline C, Ball, Sarah, Hutzen, Brian, Sasser, A Kate, Lin, Huey-Jen, Huang, Tim HM, Hall, Brett M, Lin, Jiayuh
Publicado em 2008

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

Por Casneuf, Tineke, Axel, Amy E, King, Peter, Alvarez, John D, Werbeck, Jillian L, Verhulst, Tinne, Verstraeten, Karin, Hall, Brett M, Sasser, A Kate
Publicado no Breast Cancer (Dove Med Press) (2016)

Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6

Por Chaturvedi, Shalini, Siegel, Derick, Wagner, Carrie L, Park, Jaehong, van de Velde, Helgi, Vermeulen, Jessica, Fung, Man-Cheong, Reddy, Manjula, Hall, Brett, Sasser, Kate
Publicado no Br J Clin Pharmacol (2015)

Melphalan exposure induces an Interleukin-6 deficit in bone marrow stromal cells and osteoblasts

Por Rellick, Stephanie L., Piktel, Debbie, Walton, Cheryl, Hall, Brett, Petros, William, Fortney, James E., Gencheva, Marieta, Denvir, Jim, Hobbs, Gerald, Craig, Michael, Gibson, Laura F.
Publicado em 2012

Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor)

Por Lagmay, Joanne P., London, Wendy B., Gross, Thomas G., Termuhlen, Amanda, Sullivan, Nicholas, Axel, Amy, Mundy, Bethany, Ranalli, Mark, Canner, Jason, McGrady, Patrick, Hall, Brett
Publicado em 2009

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels

Por Stone, Katie, Woods, Emily, Szmania, Susann M., Stephens, Owen W., Garg, Tarun K., Barlogie, Bart, Shaughnessy, John D., Hall, Brett, Reddy, Manjula, Hoering, Antje, Hansen, Emily, van Rhee, Frits
Publicado em 2013

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα(2) through IRF9

Por Erb, Holger H H, Langlechner, Regina V, Moser, Patrizia L, Handle, Florian, Casneuf, Tineke, Verstraeten, Karin, Schlick, Bettina, Schäfer, Georg, Hall, Brett, Sasser, Kate, Culig, Zoran, Santer, Frédéric R
Publicado em 2013

NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma

Por Wang, Huating, Garzon, Ramiro, Sun, Hao, Ladner, Katherine J., Singh, Ravi, Dahlman, Jason, Cheng, Alfred, Hall, Brett M., Qualman, Stephen J., Chandler, Dawn S., Croce, Carlo M., Guttridge, Denis C.
Publicado em 2008

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

Por Voorhees, Peter M., Manges, Robert F., Sonneveld, Pieter, Jagannath, Sundar, Somlo, George, Krishnan, Amrita, Lentzsch, Suzanne, Frank, Richard C., Zweegman, Sonja, Wijermans, Pierre W., Orlowski, Robert Z., Kranenburg, Britte, Hall, Brett, Casneuf, Tineke, Qin, Xiang, van de Velde, Helgi, Xie, Hong, Thomas, Sheeba K.
Publicado no Br J Haematol (2013)